» Articles » PMID: 31650096

MiT/TFE Family of Transcription Factors, Lysosomes, and Cancer

Overview
Publisher Annual Reviews
Date 2019 Oct 26
PMID 31650096
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cells have an increased demand for energy sources to support accelerated rates of growth. When nutrients become limiting, cancer cells may switch to nonconventional energy sources that are mobilized through nutrient scavenging pathways involving autophagy and the lysosome. Thus, several cancers are highly reliant on constitutive activation of these pathways to degrade and recycle cellular materials. Here, we focus on the MiT/TFE family of transcription factors, which control transcriptional programs for autophagy and lysosome biogenesis and have emerged as regulators of energy metabolism in cancer. These new findings complement earlier reports that chromosomal translocations and amplifications involving the MiT/TFE genes contribute to the etiology and pathophysiology of renal cell carcinoma, melanoma, and sarcoma, suggesting pleiotropic roles for these factors in a wider array of cancers. Understanding the interplay between the oncogenic and stress-adaptive roles of MiT/TFE factors could shed light on fundamental mechanisms of cellular homeostasis and point to new strategies for cancer treatment.

Citing Articles

Isowalsuranolide targets TrxR1/2 and triggers lysosomal biogenesis and autophagy via the p53-TFEB/TFE3 axis.

Yang X, Ding X, Zhao Y, Wang Y, Dong X, Niu Z Sci China Life Sci. 2025; .

PMID: 40059270 DOI: 10.1007/s11427-023-2563-6.


Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinoma.

Li J, Huang K, Thakur M, McBride F, Sadagopan A, Gallant D Nat Metab. 2025; .

PMID: 39915638 DOI: 10.1038/s42255-025-01218-9.


Non-Canonical, Extralysosomal Activities of Lysosomal Peptidases in Physiological and Pathological Conditions: New Clinical Opportunities for Cancer Therapy.

Conesa-Bakkali R, Morillo-Huesca M, Martinez-Fabregas J Cells. 2025; 14(2).

PMID: 39851495 PMC: 11763575. DOI: 10.3390/cells14020068.


NFκB and JNK pathways mediate metabolic adaptation upon ESCRT-I deficiency.

Cendrowski J, Wrobel M, Mazur M, Jary B, Maurya R, Wang S Cell Mol Life Sci. 2024; 81(1):458.

PMID: 39560723 PMC: 11576715. DOI: 10.1007/s00018-024-05490-y.


Unveiling GATOR2 Function: Novel Insights from Drosophila Research.

Bettedi L, Zhang Y, Yang S, Lilly M Cells. 2024; 13(21.

PMID: 39513902 PMC: 11545208. DOI: 10.3390/cells13211795.


References
1.
Buerger C, DeVries B, Stambolic V . Localization of Rheb to the endomembrane is critical for its signaling function. Biochem Biophys Res Commun. 2006; 344(3):869-80. DOI: 10.1016/j.bbrc.2006.03.220. View

2.
Strohecker A, Guo J, Karsli-Uzunbas G, Price S, Chen G, Mathew R . Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov. 2013; 3(11):1272-85. PMC: 3823822. DOI: 10.1158/2159-8290.CD-13-0397. View

3.
Zhou Y, Tang F, Wang Y, Min L, Luo Y, Zhang W . Advanced alveolar soft part sarcoma responds to apatinib. Oncotarget. 2017; 8(30):50314-50322. PMC: 5564851. DOI: 10.18632/oncotarget.18599. View

4.
Ying H, Dey P, Yao W, Kimmelman A, Draetta G, Maitra A . Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2016; 30(4):355-85. PMC: 4762423. DOI: 10.1101/gad.275776.115. View

5.
Argani P, Lal P, Hutchinson B, Lui M, Reuter V, Ladanyi M . Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003; 27(6):750-61. DOI: 10.1097/00000478-200306000-00005. View